- Home
- KRKR vs ONVO Comparison
KRKR vs ONVO Comparison
Compare KRKR & ONVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRKR
- ONVO
- Stock Information
- Founded
- KRKR 2010
- ONVO 2007
- Country
- KRKR China
- ONVO United States
- Employees
- KRKR N/A
- ONVO N/A
- Industry
- KRKR Business Services
- ONVO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- KRKR Consumer Discretionary
- ONVO Health Care
- Exchange
- KRKR Nasdaq
- ONVO Nasdaq
- Market Cap
- KRKR 6.6M
- ONVO 6.5M
- IPO Year
- KRKR 2019
- ONVO N/A
- Fundamental
- Price
- KRKR $3.52
- ONVO $0.35
- Analyst Decision
- KRKR
- ONVO
- Analyst Count
- KRKR 0
- ONVO 0
- Target Price
- KRKR N/A
- ONVO N/A
- AVG Volume (30 Days)
- KRKR 19.8K
- ONVO 245.2K
- Earning Date
- KRKR 09-03-2024
- ONVO 02-06-2025
- Dividend Yield
- KRKR N/A
- ONVO N/A
- EPS Growth
- KRKR N/A
- ONVO N/A
- EPS
- KRKR N/A
- ONVO N/A
- Revenue
- KRKR $41,654,350.00
- ONVO $103,000.00
- Revenue This Year
- KRKR $45.99
- ONVO $59.08
- Revenue Next Year
- KRKR $31.46
- ONVO $18.24
- P/E Ratio
- KRKR N/A
- ONVO N/A
- Revenue Growth
- KRKR N/A
- ONVO N/A
- 52 Week Low
- KRKR $2.76
- ONVO $0.32
- 52 Week High
- KRKR $12.20
- ONVO $1.74
- Technical
- Relative Strength Index (RSI)
- KRKR 51.29
- ONVO 44.33
- Support Level
- KRKR $3.21
- ONVO $0.35
- Resistance Level
- KRKR $3.60
- ONVO $0.51
- Average True Range (ATR)
- KRKR 0.21
- ONVO 0.05
- MACD
- KRKR 0.04
- ONVO -0.00
- Stochastic Oscillator
- KRKR 66.86
- ONVO 13.33
About KRKR 36Kr Holdings Inc.
36KR Holdings Inc is a holding company and conducts its business mainly through its subsidiaries, a VIE, and subsidiaries of the VIE. The Group is engaging in providing content and business services to new economy participants in the PRC. Its content production process includes content creation, content editing, screening and monitoring, and content distribution. The Group mainly generates revenues from providing online advertising services, enterprise value-added services, and subscription services. The Group's principal operations and geographic markets are substantially located in PRC.
About ONVO Organovo Holdings Inc.
Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases.